Science Exchange, the leading marketplace for outsourced R&D™,
announces a collaboration with LI-COR Biosciences to offer a suite of
molecular imaging services based on LI-COR’s pioneer work in
near-infrared fluorescence as a detection method.
Based in Lincoln, Nebraska, LI-COR Biosciences is a world leader in
innovative imaging systems for proteomics and pre-clinical research.
With more than 25 years of experience in providing molecular imaging
technologies worldwide, the company now offers a broad range of custom
research services for scientists. From development through screening,
LI-COR is positioned to lend wide-ranging R&D assistance to scientists
with a special emphasis on western blot reproducibility.
“Working with Science Exchange allows us to reach key researchers
focusing on pre-clinical and clinical translation applications,” says
Greg Biggs, CEO of LI-COR. “Building on our established expertise in
Western blot assays, protocol, and probe development and optimization,
we can now offer our unique expertise in expanded areas of focus for
custom services including validation, manufacturing, and analytical
“Teaming up with LI-COR provides researchers with access to unique, in
some cases, one of a kind services and products,” said Elizabeth Iorns,
Ph.D., co-founder and CEO of Science Exchange. “LI-COR has a clear
leadership role in advancing imaging technology especially in the use of
About Science Exchange
Science Exchange is the world’s leading marketplace for outsourced
R&D™, providing large R&D organizations with the fastest path
from discovery through development and commercialization. Science
Exchange includes an efficient source-to-secure platform for ordering
6,000+ services from a network of more than 2,500 qualified outsourced
research providers, all with pre-established contracts in place that
protect client intellectual property and confidentiality. The platform
increases access to innovation and improves productivity, freeing
scientists from administrative tasks and delays associated with
sourcing, establishing and managing service provider contracts.
Additionally, the Science Exchange enterprise program enables large R&D
organizations to consolidate research outsourcing spend into a single
strategic relationship, driving efficiency, improving transparency and
oversight, and delivering cost savings. Since being founded in 2011,
Science Exchange has raised more than $58 million from Norwest Venture
Partners, Maverick Capital Ventures, Union Square Ventures,
Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and
others. For more information, visit www.ScienceExchange.com.
Follow the company on Twitter @ScienceExchange.
About LI-COR Biosciences
LI-COR Biosciences is a pioneer in the development of near-infrared
fluorescence labeling and detection systems for such areas as drug
discovery, genomics, and small animal in vivo imaging. LI-COR
provides the complete solution for quantitative Western blots with its
Odyssey® Infrared Imaging Systems, C-DiGit® Chemiluminescent Blot
Scanner, Image Studio™ analysis software, unique IRDye® secondary
antibodies, and reagents. For small animal imaging the company offers
BrightSite™ near-infrared fluorescent probes or bioluminescence on the
Pearl® Trilogy imaging system. LI-COR IRDye near-infrared dyes are being
used in human clinical trials for potential therapeutic and diagnostic
applications including cancer treatments and surgical visualization. For
more information, visit www.licor.com/bio.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180710005813/en/